3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
15
Phase NA
11
Phase 3
4
Phase 1/2
3
Phase 1
1
Status
Recruiting
2
Terminated
1
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
4
Sponsor
Cancer Type
Breast
4
Conditions
Breast Neoplasms
4
Interventions
Cisplatin
726
Carboplatin
609
Paclitaxel
579
Cyclophosphamide
516
Radiotherapy
511
Docetaxel
477
Fluorouracil
454
Gemcitabine
438
Doxorubicin
383
Capecitabine
362
Dexamethasone
328
Oxaliplatin
289
pembrolizumab
283
Leucovorin
283
Bevacizumab
275
Etoposide
272
Vincristine
270
Rituximab
246
Prednisone
223
Pemetrexed
217
Cytarabine
205
Drug Therapy
194
Trastuzumab
176
Irinotecan
174
Methotrexate
171
Lenalidomide
137
Nivolumab
136
Filgrastim
135
Epirubicin
129
Tamoxifen
128
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
Mastectomy
×
Clear all
NCT00210236
2025-10-20
AXIL95
Institut Bergonié
Phase 3
Terminated
625 enrolled
8 charts
NCT06839001
2025-06-26
CRYSTAL - SIX
Hospital do Coracao
Phase 3
Recruiting
750 enrolled
NCT05440149
2024-11-29
PORT-N1
Seoul National University Hospital
Phase 3
Recruiting
1,106 enrolled
NCT01901146
2019-08-07
Lilac
Amgen
Phase 3
Completed
725 enrolled
18 charts